Viewing Study NCT04654403


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-25 @ 4:43 PM
Study NCT ID: NCT04654403
Status: UNKNOWN
Last Update Posted: 2021-08-23
First Post: 2020-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module